Nephro-Urology Monthly

Published by: Kowsar

Frequency and Associated Factors of Amphotericin B Nephrotoxicity in Hospitalized Patients in Hematology-Oncology Wards in the Southwest of Iran

Iman Karimzadeh 1 , Marziyeh Heydari 1 , Mani Ramzi 2 and Mohammad Mahdi Sagheb 3 , *
Authors Information
1 Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Hematology Research Center, Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Nephrology-Urology Research Center, Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Nephro-Urology Monthly: September 01, 2016, 8 (5); e39581
  • Published Online: July 3, 2016
  • Article Type: Research Article
  • Received: June 6, 2016
  • Accepted: June 15, 2016
  • DOI: 10.5812/numonthly.39581

To Cite: Karimzadeh I, Heydari M, Ramzi M, Sagheb M M. Frequency and Associated Factors of Amphotericin B Nephrotoxicity in Hospitalized Patients in Hematology-Oncology Wards in the Southwest of Iran, Nephro-Urol Mon. 2016 ; 8(5):e39581. doi: 10.5812/numonthly.39581.

Abstract
Copyright © 2016, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Sheppard D, Lampiris HW. Antifungal Agents. Basic and Clinical Pharmacology. 2011;
  • 2. Ulozas E. Amphotericin B-Induced Nephrotoxicity. 2010; : 347-57[DOI]
  • 3. Karimzadeh I, Khalili H, Sagheb MM. Preventing or attenuating amphotericin B nephrotoxicity with dopamine receptor agonists: a literature review. Trend Phram Sci. 2015; 1(3): 129-38
  • 4. Bennett JE. Antimicrobial agents: antifungal agents. Goodman and gilman's the pharmacological basis of therapeutics. 2010;
  • 5. Laniado-Laborin R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam Micol. 2009; 26(4): 223-7[DOI][PubMed]
  • 6. Karimzadeh I, Khalili H, Farsaei S, Dashti-Khavidaki S, Sagheb MM. Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity. Eur J Clin Pharmacol. 2013; 69(7): 1351-68[DOI][PubMed]
  • 7. Khwaja A. KDIGO Clinical practice guideline for acute kidney injury. Nephron Clin Pract. 2012; 120(4)-84[DOI][PubMed]
  • 8. National Kidney Foundation. KDOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1)-266[PubMed]
  • 9. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990; 12(2): 308-29[PubMed]
  • 10. Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med. 2001; 111(7): 528-34[PubMed]
  • 11. Goldman RD, Koren G. Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol. 2004; 26(7): 421-6[PubMed]
  • 12. Sharfuddin AA, Weisbord SD, Palevsky PM, Molitoris BA. Acute kidney injury. Brenner and Rector’s The Kidney. 2012: chap 30;
  • 13. Common Terminology Criteria for Adverse Events (CTCAE). 2010;
  • 14. Mount DB. , Sterns RH, Emmett M. Evaluation of the patient with hypokalemia. 2016;
  • 15. Tavakoli-Ardakani M, Eshraghi A, Hajhossein Talasaz A, Salamzadeh J. A drug utilization evaluation study of amphotericin B in neutropenic patients in a teaching hospital in iran. Iran J Pharm Res. 2012; 11(1): 151-6[PubMed]
  • 16. Hayatshahi A, Javadi M, Torkamandi H, Hadjibabaie M, Hanafi S, Gholami K, et al. Drug utilization review of conventional amphotericin b in febrile neutropenic patients hospitalized at a bone marrow transplant center. Int J Hematol-Oncol Stem Cell Rese. 2010; 4(2): 1-3
  • 17. Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iran. 2013; 51(12): 871-8[PubMed]
  • 18. Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity? Expert Opin Drug Saf. 2012; 11(6): 969-83[DOI][PubMed]
  • 19. Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, et al. Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int. 2001; 60(4): 1452-9[DOI][PubMed]
  • 20. Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001; 32(5): 686-93[DOI][PubMed]
  • 21. Fisher MA, Talbot GH, Maislin G, McKeon BP, Tynan KP, Strom BL. Risk factors for Amphotericin B-associated nephrotoxicity. Am J Med. 1989; 87(5): 547-52[PubMed]
  • 22. Luber AD, Maa L, Lam M, Guglielmo BJ. Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother. 1999; 43(2): 267-71[PubMed]
  • 23. Goldman RD, Ong M, Wolpin J, Doyle J, Parshuram C, Koren G. Pharmacological risk factors for amphotericin B nephrotoxicity in children. J Clin Pharmacol. 2007; 47(8): 1049-54[DOI][PubMed]
  • 24. Barrett JP, Vardulaki KA, Conlon C, Cooke J, Daza-Ramirez P, Evans EG, et al. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther. 2003; 25(5): 1295-320[PubMed]
  • 25. Wazny LD, Brophy DF. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia. Ann Pharmacother. 2000; 34(1): 94-7[PubMed]
  • 26. Atsmon J, Dolev E. Drug-induced hypomagnesaemia : scope and management. Drug Saf. 2005; 28(9): 763-88[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments